Systems biology of metabolism

Annual Review of Biochemistry

Volumn 86, Issue , 2017, Pages 245-275

  Nielsen, Jens ^a,b,c  

^a CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^c ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

Author keywords

Genome scale metabolic models; Metabolic engineering; Metabolomics; Proteomics; Systems medicine; Transcriptomics

Indexed keywords

PROTEOME; TRANSCRIPTOME;

BIOMICS; CELL METABOLISM; ESCHERICHIA COLI; FLUXOMICS; GENETIC ENGINEERING; GENOME SCALE METABOLIC MODEL; HAEMOPHILUS INFLUENZAE; HELICOBACTER PYLORI; HUMAN; LACTOCOCCUS LACTIS; MATHEMATICAL MODEL; METABOLIC ENGINEERING; METABOLOMICS; MICHAELIS MENTEN KINETICS; MICROBIAL METABOLISM; MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SACCHAROMYCES CEREVISIAE; SYSTEMS BIOLOGY; TRANSCRIPTOMICS; BACTERIUM; BIOLOGICAL MODEL; FUNGUS; GENETICS; GENOME; KINETICS; METABOLISM; PROCEDURES; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

BACTERIA; FUNGI; GENOME; HUMANS; KINETICS; METABOLIC ENGINEERING; METABOLOMICS; MODELS, BIOLOGICAL; MODELS, STATISTICAL; PROTEOMICS; SYSTEMS BIOLOGY; TRANSCRIPTOME;

EID: 85021651714     PISSN: 00664154     EISSN: 15454509     Source Type: Book Series    
DOI: 10.1146/annurev-biochem-061516-044757     Document Type: Review

References (181)

1. Keller MA, Turchyn A, Ralser M. (2014). Non-enzymatic glycolysis and pentose phosphate pathway-like reactions in a plausible Archean ocean. Mol. Syst. Biol. 10: 725
2. Herzig S, Raemy E, Montessult S, Veuthey JL, Westermann B, et al. (2012). Identification and functional expression of the mitochondrial pyruvate carrier. Science 337: 93-96
3. Bricker DK, Taylor EB, Schell JC, Orsak T, Boutron A, et al. (2012). A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans. Science 337: 96-100
4. Nielsen J. (2003). It is all about metabolic fluxes. J. Bacteriol. 185: 7031-35
5. Vidal M. (2009). A unifying view of 21st century systems biology. FEBS Lett. 583: 3891-94
6. Kell DB, Oliver SG. (2004). Here is the evidence, now what is the hypothesis? The complementary roles of inductive and hypothesis-driven science in the post-genomic era. BioEssays 26: 99-105
7. Jewett MC, Nielsen J. (2008). Impact of systems biology on metabolic engineering of Saccharomyces cerevisiae. FEMS Yeast Res. 8: 122-31
8. Noble D. (1960). Cardiac action and pacemaker potentials based on the Hodkin-Huxley equations. Nature 188: 495-97
9. Fredrickson AG, Megee RD, Tsuchiya HM. (1970). Mathematical models for fermentation processes. Adv. Appl. Microbiol. 13: 419-65
10. Heinrich R, Rapoport TA. (1974). A linear steady-state treatment of enzymatic chains. General properties, control and effector strength. Eur. J. Biochem. 42: 89-95
11. Kacser H, Burns JA. (1973). The control of flux. Symp. Soc. Exp. Biol. 27: 65-104
12. Kell DB, van Dam K, Westerhoff HV. (1989). Control analysis of microbial growth and productivity. Symp. Soc. Gen. Microbiol. 44: 61-93
13. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000). Gene ontology: tool for the unification of biology. Nat. Genet. 25: 25-29
14. Ideker T, Thorsson V, Ranish JA, Christmas R, Buhler J, et al. (2001). Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science 292: 929-34
15. Ideker T, Galitski T, Hood L. (2001). A new approach to decoding life: systems biology. Annu. Rev. Genom. Hum. Genet. 2: 343-72
16. Kitano H. (2002). Computational systems biology. Nature 420: 206-10
17. Kitano H. (2002). Systems biology: a brief overview. Science 295: 1662-64
18. Domach MM, Leung SK, Cahn RE, Cocks GG, Shuler ML. (1984). Computer model for glucose-limited growth of a single cell of Escherichia coli B/r-A. Biotechnol. Bioeng. 26: 203-16
19. Tomita M, Hashimoto K, Takahashi K, Shimizu TS, Matsuzaki Y, et al. (1999). E-CELL: software environment for whole-cell simulation. Bioinformatics 15: 72-84
20. Karr JR, Sanghvi JC, MacKlin DN, Gutschow MV, Jacobs JM, et al. (2012). A whole-cell computational model predicts phenotype from genotype. Cell 150: 389-401
21. Bar-Even A, Noor E, Savir Y, Liebermeister W, Davidi D, et al. (2011). The moderately efficient enzyme: evolutionary and physicochemical trends shaping enzyme parameters. Biochemistry 50: 4402-10
22. Nilsson A, Nielsen J. (2016). Metabolic trade-offs in yeast are caused by F1F0-ATP synthase. Sci. Rep. 6: 22264
23. Rizzi M, Baltes M, Theobald U, Reuss M. (1997). In vivo analysis of metabolic dynamics in Saccharomyces cerevisiae: II. Mathematical model. Biotechnol. Bioeng. 55: 592-608
24. Chassagnole C, Noissomit-Rizzi N, Schmid JW, Mauch K, Reuss M. (2002). Dynamic modeling of the central carbon metabolism of E coli. Biotechnol. Bioeng. 79: 53-73
25. Schaff I, Heinisch J, Zimmermann FK. (1989). Overproduction of glycolytic enzymes in yeast. Yeast 5: 285-290
26. Smits HP, Hauf J, Müller S, Hobley TJ, Zimmermann FK, et al. (2000). Simultaneous overexpression of enzymes of the lower part of glycolysis can enhance fermentative capacity of Saccharomyces cerevisiae. Yeast 16: 1325-34
27. Koebmann BJ, Solem C, Pedersen MB, Nilsson D, Jensen PR. (2002). Expression of genes encoding F1-ATPase results in uncoupling of glycolysis from biomass production in Lactococcus lactis. Appl. Environ. Microbiol. 68: 4274-82
28. Teusink B, Walsch MC, van Dam K, Westerhoff HV. (1998). The danger of metabolic pathways with turbo design. Trends Biochem. Sci. 23: 162-69
29. van de Poll K, Kerkenaar A, Schamhart DHJ. (1974). Isolation of a regulatory mutant of fructose-1, 6-diphosphatase in Saccharomyces cerevisiae. J. Bacteriol. 117: 965-70
30. van Heerden JH, Wortel MT, Bruggeman FJ, Heijnen JJ, Bollen YJ, et al. (2014). Lost in transition: start-up of glycolysis yields subpopulations of non-growing cells. Science 343: 1245114
31. Fraenkel D, Nielsen J. (2016). Trehalose-6-phosphate synthase and stabilization of yeast glycolysis. FEMS Yeast Res. 16: fov100
32. Klipp E, Nordlander B, Krüger R, Gennemark P, Hohmann S. (2005). Integrative model of the response of yeast to osmotic shock. Nat. Biotechnol. 23: 975-82
33. Heinrich R, Neel BG, Rapoport TA. (2002). Mathematical models of protein kinase signal transduction. Mol. Cell 9: 957-70
34. Petelenz-Kurdziel E, Kuehn C, Nordlander B, Klein D, Hong K-K, et al. (2012). Quantitative analysis of glycerol accumulation, glycolysis and growth under hyper osmotic stress. PLOS Comput. Biol. 9: e1003084
35. Edwards JS, Palsson BO. (1999). Systems properties of the Haemophilus influenzae Rd metabolic genotype. J. Biol. Chem. 274: 17410-16
36. Edwards JS, Palsson BO. (2001). The Escherichia coli MG1655 in silico metabolic genotype. Its definition, characteristics, and capabilities. PNAS 97: 5528-33
37. Schilling CH, Covert MW, Famili I, Church GM, Edwards JS, et al. (2002). Genome-scale metabolic model of Helicobacter pylori 26695. J. Bacteriol. 184: 4582-93
38. Förster J, Famili I, Fu P, Palsson BO, Nielsen J. (2003). Genome-scale metabolic reconstruction of the Saccharomyces cerevisiae metabolic network. Genome Res. 13: 244-53
39. Famili I, Förster J, Nielsen J, Palsson BO. (2003). Saccharomyces cerevisiae phenotypes can be predicted by using constraint-based analysis of a genome-scale reconstructedmetabolic network. PNAS 100: 13134-39
40. Kim TY, Sohn SB, Kim YB, Kim WJ, Lee SY. (2012). Recent advances in reconstruction and applications of genome-scale metabolic models. Curr. Opin. Biotechnol. 23: 617-23
41. Monk J, Nogales J, Palsson BO. (2014). Optimizing genome-scale network reconstructions. Nat. Biotechnol. 32: 447-52
42. Collakova E, Yen JY, Senger RS. (2012). Are we ready for genome-scale modeling in plants? Plant Sci. 191-192: 53-70
43. Orth JB, Conrad TM, Na J, Lerman JA, Nam H, et al. (2011). A comprehensive genome-scale reconstruction of Escherichia coli metabolism-2011. Mol. Syst. Biol. 7: 535
44. Aung HW, Henry SA, Walker LP. (2013). Revising the representation of fatty acid, glycerolipid, and glycerophospholipid metabolism in the consensus model of yeast metabolism. Ind. Biotechnol. 9: 215-29
45. Andersen MR, Nielsen ML, Nielsen J. (2008). Metabolic model integration of the bibliome, genome, metabolome and reactome of Aspergillus niger. Mol. Syst. Biol. 4: 178
46. Agren R, Liu L, Shoaie S, Vongsangnak W, Nookaew I, et al. (2013). The RAVEN toolbox and its use for generating a genome-scale metabolic model for Penicillium chrysogenum. PLOS Comput. Biol. 9: e1002980
47. McCloskey D, Palsson BO, Feist AM. (2013). Basic and applied uses of genome-scale metabolic network reconstructions of Escherichia coli. Mol. Syst. Biol. 9: 661
48. Sanchez BJ, Nielsen J. (2015). Genome scale models of yeast: towards standardized evaluation and consistent omic integration. Integr. Biol. 7: 846-58
49. HerrgÅrd MJ, Swainston N, Dobson P, Dunn WB, Arga KY, et al. (2008). A consensus yeast metabolic network reconstruction obtained from a community approach to systems biology. Nat. Biotechnol. 26: 1155-60
50. Heavner BD, Smallbone K, Price ND, Walker LP. (2013). Version 6 of the consensus yeast metabolic network refines biochemical coverage and improves model performance. Database 2013: bat059
51. Aiba S, Matsuoka M. (1979). Identification ofmetabolic model: citrate production from glucose by Candida lipolytica. Biotechnol. Bioeng. 21: 1373-86
52. Fell DA, Small JK. (1986). Fat synthesis in adipose tissue. An examination of stoichiometric constraints. Biochem. J. 238: 781-86
53. Edwards JS, Ibarra RU, Palsson BO. (2001). In silico predictions of Escherichia coli metabolic capabilities are consistent with experimental data. Nat. Biotechnol. 19: 125-30
54. Schuetz R, Kuepfer L, Sauer U. (2007). Systematic evaluation of objective functions for predicting intracellular fluxes in Escherichia coli. Mol. Syst. Biol. 3: 119
55. O'Brien EJ, Monk JM, Palsson BO. (2015). Using genome-scale models to predict biological capabilities. Cell 161: 971-87
56. Ibarra RU, Edwards JS, Palsson BO. (2002). Escherichia coli K12 undergoes adaptive evolution to achieve in silico predicted optimal growth. Nature 420: 186-89
57. Fischer E, Sauer U. (2005). Large-scale metabolic in vivo flux analysis shows rigidity and suboptimal performance of Bacillus subtilis metabolism. Nat. Genet. 37: 636-40
58. Chakrabarti A, Miskovic L, Soh KC, Hatzimanikatis V. (2013). Towards kinetic modeling of genome-scale metabolic networks without sacrificing stoichiometric, thermodynamic and physiological constraints. Biotechnol. J. 8: 1043-57
59. Thiele I, Ronan MTF, Que R, Bordbar A, Diep D, et al. (2012). Multiscale modeling of metabolism and macromolecular synthesis in E coli and its applications to the evolution of codon usage. PLOS ONE 7: e45635
60. Chang RL, Andrews K, Kim D, Li Z, Godzik A, et al. (2013). Structural systems biology evaluation of metabolic thermotolerance of Escherichia coli. Science 340: 1220-23
61. Feizi A, Österlund T, Petranovic D, Bordel S, Nielsen J. (2013). Genome-scale modeling of the protein secretion machinery in yeast. PLOS ONE 8: e63284
62. Ideker T, Ozier O, Schwikowski B, Siegel AF. (2002). Discovering regulatory and signaling circuits in molecular interaction networks. Bioinformatics 18: S233-40
63. Patil KR, Nielsen J. (2005). Uncovering transcriptional regulation of metabolism by using metabolic network topology. PNAS 102: 2685-89
64. Oliveira A, Patil KR, Nielsen J. (2008). Architecture of transcriptional regulatory circuits is knitted over the topology of bio-molecular interaction networks. BMC Syst. Biol. 2: 17
65. Väremo L, Nielsen J, Nookaew I. (2013). Enriching the gene set analysis of genome-wide data by incorporating directionality of gene expression and combining statistical hypothesis and methods. Nucleic Acids Res. 41: 4378-91
66. DeRisi JL, Iyer VR, Brown PO. (1997). Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 278: 680-86
67. Å kesson M, Förster J, Nielsen J. (2004). Integration of gene expression data into genome-scale metabolic models. Metab. Eng. 6: 285-93
68. Machado D, HerrgÅrd M. (2014). Systematic evaluation of methods for integration of transcriptomic data into constraint-based models of metabolism. PLOS Comput. Biol. 10: e1003580
69. O'Brien EJ, Lerman JA, Chang RL, Hyduke DR, Palsson BO. (2013). Genome-scale models of metabolism and gene expression extend and refine growth phenotype predictions. Mol. Syst. Biol. 9: 693
70. Fendt S-M, Oliveira AP, Christen S, Picotti P, Dechant RC, et al. (2010). Unraveling condition-dependent networks of transcription factors that control metabolic pathway activity in yeast. Mol. Syst. Biol. 6: 432
71. Harbison CT, Gordon DB, Lee TI, Rinaldi NJ, Macisaac KD, et al. (2004). Transcriptional regulatory code of a eukaryotic genome. Nature 431: 99-104
72. Hughes TR, de Boer CG. (2013). Mapping yeast transcriptional networks. Genetics 195: 9-36
73. Österlund T, Bordel S, Nielsen J. (2015). Controllability analysis of transcriptional regulatory networks reveals circular control patterns among transcription factors. Integr. Biol. 7: 560-68
74. Liu G, Bergenholm D, Nielsen J. (2016). Genome-wide mapping of binding sites reveals multiple biological functions of the transcription factor Cst6 in Saccharomyces cerevisiae. mBio 7: e00559-16
75. Cho B-K, Federowicz S, Park Y-S, Zengler K, Palsson BO. (2011). Deciphering the transcriptional regulatory logic of amino acid metabolism. Nat. Chem. Biol. 8: 65-71
76. Rossell S, van der Weijden CC, Lindenbergh A, van Tuijl A, Francke C, et al. (2006). Unraveling the complexity of flux regulation: a new method demonstrated for nutrient starvation in Saccharomyces cerevisiae. PNAS 103: 2166-71
77. Chubukov V, Uhr M, Le Chat L, Kleijn RJ, Jules M, et al. (2013). Transcriptional regulation is insufficient to explain substrate-induced flux changes in Bacillus subtilis. Mol. Syst. Biol. 9: 709
78. Gerosa L, Haverkorn van Rijsewijk BRB, Christodoulou D, Kochanowski K, Schmidt TSB, et al. (2015). Pseudo-Transition analysis identifies the key regulators of dynamic metabolic adaptations from steadystate data. Cell Syst. 1: 270-82
79. Bordel S, Agren R, Nielsen J. (2010). Sampling the solution space in genome-scale metabolic networks reveals transcriptional regulation in key enzymes. PLOS Comput. Biol. 6: e1000859
80. Marguerat S, Schmidt A, Codlin S, Chen W, Aebershold R, et al. (2012). Quantitative analysis of fission yeast transcriptomes and proteomes in proliferating and quiescent cells. Cell 151: 671-83
81. Schmidt A, Kochanowski K, Vedelaar S, Ahrne E, Volkmer B, et al. (2016). The quantitative and conditiondependent Escherichia coli proteome. Nat. Biotechnol. 34: 104-10
82. Canelas AB, Harrison N, Fazio A, Zhang J, Pitkänen JP, et al. (2010). Integrated multilaboratory systems biology reveals differences in protein metabolism between two reference yeast strains. Nat. Commun. 1: 145
83. Hong K-K, Hou J, Shoaie S, Nielsen J, Bordel S. (2012). Dynamic 13C-labeling experiments prove important differences in protein turnover rate between two Saccharomyces cerevisiae strains. FEMS Yeast Res. 12: 741-47
84. Kafri MN, Metzi-Raz E, Jona G, Barkai N. (2016). The costs of protein synthesis. Cell Rep. 14: 1-10
85. Scott M, Gunderson CW, Mateescu EM, Zhong Z, Hwa T. (2010). Interdependence of cell growth and gene expression: origins and consequences. Science 330: 1099-102
86. Basan M, Hui S, Okano H, Zhang Z, Shen Y, et al. (2015). Overflow metabolism in Escherichia coli results from efficient proteome allocation. Nature 528: 99-104
87. Theobald U, Mailinger W, Baltes M, Rizzi M, Reuss M. (1997). In vivo analysis of metabolic dynamics in Saccharomyces cerevisiae: I. Experimental observations. Biotechnol. Bioeng. 55: 305-16
88. Villas-Boas SG, Højer-Pedersen J, Å kesson M, Smedsgaard J, Nielsen J (2005). Globalmetabolite analysis of yeast: evaluation of sample preparation methods. 22: 1155-69
89. Link H, Fuhrer T, Gerosa L, Zamboni N, Sauer U. (2015). Real-Time metabolome profiling of the metabolic switch between starvation and growth. Nat. Methods 12: 1091-97
90. Cakir T, Patil KR, Önsan ZI, Ülgen KÖ, Kirdar B, et al. (2006). Integration of metabolome data with metabolic networks reveals reporter reactions. Mol. Syst. Biol. 2: 50
91. Nielsen J, Oliver S. (2005). The next wave in metabolome analysis. Trends Biotechnol. 23: 544-46
92. Wiechert W. (2001). 13C metabolic flux analysis. Metab. Eng. 3: 195-206
93. Zamboni N. (2011). 13C metabolic flux analysis in complex systems. Curr. Opin. Biotechnol. 22: 103-8
94. Nöh K, Grönke K, Luo B, Takors R, Oldiges M, et al. (2007). Metabolic flux analysis at ultra short time scale: isotopically non-stationary 13C labeling experiments. J. Biotechnol. 129: 249-67
95. Leighty RW, Antoniewicz MR. (2011). Dynamic metabolic flux analysis (DMFA): a framework for determining fluxes at metabolic non-steady state. Metab. Eng. 13: 745-55
96. Maier K, Hofmann U, Bauer A, Niebel A, Vacun G, et al. (2009). Quantification of statin effects on hepatic cholesterol synthesis by transient 13C-flux analysis. Metab. Eng. 11: 292-309
97. Metallo CM, Gemeiro PA, Bell EL, Mattaini KR, Yang J, et al. (2012). Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 481: 380-84
98. Fendt S-M, Bell EL, Keibler MA, Davidson SM, Wirth GJ, et al. (2013). Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolism. Cancer Res. 73: 4429-38
99. Ying W. (2008). NAD+/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid. Redox Signal. 10: 179-206
100. Nissen T, Kielland-Brandt MC, Nielsen J, Villadsen J. (2000). Optimization of ethanol production in Saccharomyces cerevisiae by metabolic engineering of the ammonium assimilation. Metab. Eng. 2: 69-77
101. Canto C, Gerhart-Hines Z, Feige JN, Lagouge M, Noriega L, et al. (2009). AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458: 1056-60
102. Lim J-H, Lee Y-M, Chun Y-S, Chen J, Kim J-E, et al. (2010). Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1α. Mol. Cell 38: 864-78
103. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, et al. (2003). Small molecular activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425: 191-96
104. Canto C, Auwerx J. (2009). Calorie restriction, SIRT1 and longevity. Trends. Endocrinol.Metab. 20: 325-31
105. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, et al. (2006). Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444: 337-42
106. Timmers S, Konings E, Bilet L, Houtkooper RH, van deWeijer T, et al. (2011). Calorie restriction-like effects of 30 days or resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 14: 612-22
107. Beher D, Wu J, Cumine S, Kim KW, Lu S-C, et al. (2009). Resveratrol is not a direct activator of SIRT1 enzyme activity. Chem. Biol. Drug Des. 74: 619-24
108. Ehninger D, Neff F, Xie K. (2014). Longevity, aging and rapamycin. Cell. Mol. Life Sci. 71: 4325-46
109. Diaz-Troya S, Perez-Perez ME, Florencio FJ, Crespo JL. (2008). The role ofTORin autophagy regulation from yeast to plants and mammals. Autophagy 4: 851-65
110. Madeo F, Eisenberg T, Büttner T, Ruckenstuhl C, Kroemer G. (2010). Spermidine: a novel autophagy inducer and longevity elixir. Autophagy 6: 160-62
111. Usaite R, Jewett MC, Oliveira AP, Yates JR III, Olsson L, Nielsen J, et al. (2009). Reconstruction of the yeast Snf1 kinase regulatory network reveals its role as a global energy regulator. Mol. Syst. Biol. 5: 319
112. Zhang J, Vaga S, Chumnanpuen P, Kumar R, Vemuri GN, et al. (2011). Mapping the interactions of Snf1 with TORC1 in Saccharomyces cerevisiae. Mol. Syst. Biol. 7: 545
113. Garcia-Salcedo R, Lubitz T, Beltran G, Elbing K, Tian Y, et al. (2014). Glucose de-repression by yeast AMP-Activated protein kinase SNF1 is controlled via at least two independent steps. FEBS J. 281: 1901-17
114. Oliveira AP, Ludwig C, Zampieri M, Weisser H, Aebershold R, et al. (2015). Dynamic phosphoproteomics reveals TORC1-dependent regulation of yeast nucleotide and amino acid biosynthesis. Sci. Signal. 8: 1-15
115. Bailey JE. (1991). Toward a science of metabolic engineering. Science 252: 1668-74
116. Stephanopoulos G, Vallino JJ. (1991). Network rigidity and metabolic engineering in metabolite overproduction. Science 252: 1675-81
117. Nielsen J. (2001). Metabolic engineering. Appl. Microbiol. Biotechnol. 55: 263-83
118. Nielsen J, Keasling JD. (2016). Engineering cellular metabolism. Cell 164: 1185-97
119. Choi YJ, Lee SY. (2013). Microbial production of short-chain alkanes. Nature 502: 571-74
120. Zhou YJ, Buijs NA, Zhu Z, Qin J, Siewers V, et al. (2016). Production of fatty acid-derived oleochemicals and biofuels by synthetic yeast cell factories. Nat. Commun. 7: 11709
121. Steen EJ, Kang Y, Bokinsky G, Hu Z, Schirmer A, et al. (2010). Microbial production of fatty-Acid-derived fuels and chemicals from plant biomass. Nature 463: 559-62
122. Nakamura CE, Whited GM. (2003). Metabolic engineering for the microbial production of 1, 3-propanediol. Curr. Opin. Biotechnol. 14: 454-59
123. Yim H, Haselbeck R, Niu W, Pujol-Baxley C, Burgard A, et al. (2011). Metabolic engineering of Escherichia coli for direct production of 1, 4-butanediol. Nat. Chem. Biol. 7: 445-52
124. Becker J, Zelder O, Häfner S, Schr öder H, Wittmann C. (2011). From zero to hero-design-based systems metabolic engineering of Corynebacterium glutamicum for L-lysine production. Metab. Eng. 13: 159-68
125. Park JH, Lee KH, Kim TY, Lee SY. (2007). Metabolic engineering of Escherichia coli for the production of L-valine based on transcriptome analysis and in silico gene knockout simulation. PNAS 104: 7797-802
126. Scalcinati G, Knuf C, Partow S, Chen Y, Maury J, et al. (2012). Dynamic control of gene expression in Saccharomyces cerevisiae engineered for the production of plant sesquiterpene α-santalene in a fed-batch mode. Metab. Eng. 14: 91-103
127. Ro D-K, Paradise EM, Ouellet M, Fisher KJ, Newman KL, et al. (2006). Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 440: 940-43
128. Szczebara FM, Chandeller C, Villeret C, Masurel A, Dupont C, et al. (2003). Total biosynthesis of hydrocortisone from a simple carbon source in yeast. Nat. Biotechnol. 21: 143-49
129. Galanie S, Thodey K, Tenchard IJ, Interrante MF, Smolke CD. (2015). Complete biosynthesis of opioids in yeast. Science 349: 1095-100
130. Li M, Kildegaard KR, Rodriguez A, Borodina I, Nielsen J. (2015). De novo production of resveratrol from glucose or ethanol by engineered Saccharomyces cerevisiae. Metab. Eng. 32: 1-11
131. Hong K-K, Nielsen J. (2012). Metabolic engineering of Saccharomyces cerevisiae: a key cell factory platform for future biorefineries. Cell. Mol. Life Sci. 69: 2671-90
132. Nielsen J. (2015). Yeast cell factories on the horizon. Science 349: 1050-51
133. Burgard AP, Maranas CD. (2001). Probing the performance limits of the Escherichia coli metabolic network subject to gene additions or deletions. Biotechnol. Bioeng. 74: 364-75
134. Patil KR, Rocha I, Förster J, Nielsen J. (2005). Evolutionary programming as a platform for in silico metabolic engineering. BMC Bioinform. 6: 308
135. Fong SS, Burgard AP, Herring CD, Knight EM, Blattner FR, et al. (2005). In silico design and adaptive evolution of Escherichia coli for production of lactic acid. Biotechnol. Bioeng. 91: 643-48
136. Bro C, Regenberg B, Förster J, Nielsen J. (2006). In silico aided metabolic engineering of Saccharomyces cerevisiae for improved bioethanol production. Metab. Eng. 8: 102-11
137. Otero JM, Cimini D, Patil KR, Poulsen SG, Olsson L, et al. (2013). Industrial systems biology of Saccharomyces cerevisiae enables novel succinic acid cell factory. PLOS ONE 8: e54144
138. Hadadi N, Hatzimanikatis V. (2015). Design of computational retrobiosynthesis tools for the design of de novo synthetic pathways. Curr. Opin. Chem. Biol. 28: 99-104
139. Brunk E, George KW, Alonso-Gutierrez J, Thompson M, Baldoo E, et al. (2016). Characterizing strain variation in engineered E coli using a multi-omics-based workflow. Cell Syst. 2: 335-46
140. Hong K-K, Vongsangnak W, Vemuri GN, Nielsen J. (2011). Unravelling evolutionary strategies of yeast for improving galactose utilization through integrated systems level analysis. PNAS 108: 12179-84S
141. Ostergaard S, Olsson L, Johnston M, Nielsen J. (2000). Increasing galactose consumption by Saccharomyces cerevisiae through metabolic engineering of the GAL gene regulatory network. Nat. Biotechnol. 18: 1283-86
142. Bro C, Knudsen S, Regenberg B, Olsson L, Nielsen J. (2005). Improvement of galactose uptake in Saccharomyces cerevisiae through overexpression of phosphoglucomutase: example of transcript analysis as a tool in inverse metabolic engineering. Appl. Environ. Microbiol. 71: 6465-72
143. de Jongh WA, Bro C, Ostergaard S, Regenberg B, Olsson L, et al. (2008). The roles of galactitol, galactose-1-phosphate, and phosphoglucomutase in galactose-induced toxicity in Saccharomyces cerevisiae. Biotechnol. Bioeng. 101: 317-26
144. Caspeta L, Chen Y, Ghiaci P, Feizi A, Buskov S, et al. (2014). Altered sterol composition renders yeast thermotolerant. Science 346: 75-78
145. Vander Heiden MG, Cantley LC, Thompson CB. (2009). Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324: 1029-33
146. Frezza C, Zheng L, Folger O, Rajagopalan KN, MacKenzle ED, et al. (2011). Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase. Nature 477: 225-28
147. Yun J, Mullarky E, Lu C, Bosch KN, Kavalier A, et al. (2015). Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GADPH. Science 350: 1391-96
148. Mardinoglu A, Nielsen J. (2015). New paradigms for metabolic modeling of human cells. Curr. Opin. Biotechnol. 34: 91-97
149. Duarte NC, Becker SA, Jamshidi N, Thiele I, Mo ML, et al. (2007). Global reconstruction of the human metabolic network based on genomic and bibliome data. PNAS 104: 1777-82
150. Ma H, Sorokin A, Mazein A, Selkov A, Selkov E, et al. (2007). The Edinburgh human metabolic network reconstruction and its functional analysis. Mol. Syst. Biol. 3: 135
151. Thiele I, Swainston N, Fleming RMT, Hoppe A, Sahoo S, et al. (2013). A community-driven global reconstruction of human metabolism. Nat. Biotechnol. 31: 419-25
152. Agren R, Mardinoglu A, Asplund A, Kampf C, Uhlen M, et al. (2014). Identification of anticancer drugs for hepatocellular carcinoma through personalized genome-scale metabolic modeling. Mol. Syst. Biol. 10: 721
153. Mardinoglu A, Agren R, Kampf C, Asplund A, Uhlen M, et al. (2013). Integration of clinical data with a genome-scale metabolic model of the human adipocyte. Mol. Syst. Biol. 9: 949
154. Mardinoglu A, Aagren R, Kampf C, Asplund A, Uhlen M, et al. (2014). Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-Alcoholic fatty liver disease. Nat. Commun. 5: 3083
155. Väremo L, Scheele C, Broholm C, Mardinoglu A, Kampf C, et al. (2015). Proteome- and transcriptomedriven reconstruction of the human myocyte metabolic network and its use for identification of markers for diabetes. Cell Rep. 11: 1-13
156. Mardinoglu A, Bjornson E, Zhang C, Klevstig M, Söderlund S, et al. (2017). Personal model-Assisted identification of NAD+ and glutathione metabolism as intervention target in NAFLD. Mol. Syst. Biol. 13: 916
157. Shlomi T, Cabili MN, HerrgÅrd MJ, Palsson BO, Ruppin E. (2008). Network-based prediction of human tissue-specific metabolism. Nat. Biotechnol. 26: 1003-10
158. Agren R, Bordel S, Mardinoglu A, Pornputtapong N, Nookaew I, et al. (2012). Reconstruction of genomescale active metabolic networks for 60 human cell types and 16 cancer types using INIT. PLOS Comput. Biol. 8: e1002518
159. Uhlen M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, et al. (2015). Tissue-based map of the human proteome. Science 347: 1260419
160. Liu Y, Beyer A, Aebershold R. (2016). On the dependency of cellular protein levels on mRNA abundance. Cell 165: 535-50
161. Lundberg E, Fagerberg L, Klevebring D, Matic I, Geiger T, et al. (2010). Defining the transcriptome and proteome in three functionally different human cell lines. Mol. Syst. Biol. 6: 450
162. Uhlen M, Hallström BM, Lindskog C, Mardinoglu A, Ponten F, et al. (2016). Transcriptomics resources of human tissues and organs. Mol. Syst. Biol. 12: 862
163. Yizhak K, Chaneton B, Gottlieb E, Ruppin E. (2015). Modeling cancer metabolism on a genome scale. Mol. Syst. Biol. 11: 817
164. Jerby-Arnon L, Pfetzer N, Waldman YY, McGarry L, James D, et al. (2014). Predicting cancer-specific vulnerability via data-driven detection of synthetic lethality. Cell 158: 1199-209
165. Shlomi T, Benyamini T, Gottlieb E, Sharan R, Ruppin E. (2011). Genome-scale metabolic modeling elucidates the role of proliferative adaptation in causing theWarburg effect. PLOS Comput. Biol. 7: e1002018
166. Folger O, Jerby L, Frezza C, Gottlieb E, Ruppin E, et al. (2011). Predicting selective drug targets in cancer through metabolic networks. Mol. Syst. Biol. 7: 501
167. Rabinovich S, Adler L, Yizhak K, Sarver A, Silberman A, et al. (2015). Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis. Nature 527: 379-83
168. Gatto F, Nookaew I, Nielsen J. (2014). Chromosome 3p loss of heterozygosity is associated with a unique metabolic network in clear cell renal carcinoma. PNAS 111: E866-75
169. Gatto F, Volpi N, Nilsson H, Nookaew I, Maruzzo M, et al. (2016). Glycosaminoglycan profiling in patients plasma and urine predicts the occurrence of metastatic clear cell renal cell carcinoma. Cell Rep. 15: 1-15
170. Tremaroli V, Bäckhed F. (2012). Functional interactions between the gut microbiota and host metabolism. Nature 489: 242-49
171. Qin J, Li R, Raes J, Arumigam M, Burgdorf KS, et al. (2010). A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464: 59-65
172. Qin J, Li Y, Cai Z, Li S, Zhu J, et al. (2012). A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490: 55-60
173. Karlsson F, Tremaroli V, Nookaew I, Bergström G, Behre CJ, et al. (2013). Gutmetagenome in European women with normal, impaired and diabetic glucose control. Nature 498: 99-103
174. Karlsson F, Tremaroli V, Nielsen J, Bäckhed F. (2013). Assessing the human gut microbiota in metabolic diseases. Diabetes 62: 3341-49
175. Karlsson F, FÅk F, Nookaew I, Tremaroli V, Fagerberg B, et al. (2012). Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat. Commun. 3: 1245
176. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, et al. (2014). Diet rapidly and reproducibly alters the human gut microbiome. Nature 505: 559-63
177. Zelezniak A, Andrejev S, Ponomarova O, Mende DR, Bork P, et al. (2015). Metabolic dependencies drive species co-occurrence in diverse microbial communities. PNAS 112: 6449-54
178. Shoaie S, Karlsson F, Mardinoglu A, Nookaew I, Bordel S, et al. (2013). Understanding the interactions between bacteria in the human gut through metabolic modeling. Sci. Rep. 3: 2532
179. Shoaie S, Ghaffari P, Kovatcheva-Datchary P, Mardinoglu A, Sen P, et al. (2015). Quantifying diet-induced metabolic changes of the human gut microbiome. Cell Metab. 22: 320-31
180. Vetizou M, Pitt JM, Daillere R, Lepage P, Waldschmitt N, et al. (2015). Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350: 1079-84
181. Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, et al. (2015). Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350: 1084-89